BioPharma Credit PLC (FRA:B3P)
0.7750
+0.0050 (0.65%)
At close: Nov 28, 2025
BioPharma Credit Market Cap
BioPharma Credit has a market cap or net worth of €874.23 million as of December 1, 2025. Its market cap has decreased by -10.17% in one year.
Market Cap
874.23M
Enterprise Value
870.52M
Revenue
131.70M
Ranking
n/a
PE Ratio
8.34
Stock Price
€0.78
Market Cap Chart
Since March 27, 2017, BioPharma Credit's market cap has increased from 499.76M to 874.23M, an increase of 74.93%. That is a compound annual growth rate of 6.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 1, 2025 | 874.23M | -13.75% |
| Dec 31, 2024 | 1.01B | 2.39% |
| Dec 29, 2023 | 989.97M | -15.58% |
| Dec 30, 2022 | 1.17B | 0.28% |
| Dec 31, 2021 | 1.17B | 4.54% |
| Dec 31, 2020 | 1.12B | -10.42% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Mar 27, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.88B |
| Siemens Aktiengesellschaft | 176.79B |
| Allianz SE | 141.56B |
| Deutsche Telekom AG | 132.19B |
| Siemens Energy AG | 98.23B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.85B |
| Rheinmetall AG | 67.93B |
| Deutsche Bank Aktiengesellschaft | 58.37B |